PQ401, an IGF-1R inhibitor, induces apoptosis and inhibits growth, proliferation and migration of glioma cells

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of chemotherapy

• Publication date

  2016-01-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1179/1973947815Y.0000000026PMID 25971682
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Relationship between insulin‐like growth factor‐1 receptor and human papillomavirus in patients with oropharyngeal cancer

  2015cited by this paper
• Genetic variations in the IGF-IGFR-IGFBP axis confer susceptibility to lung and esophageal cancer.

  2014cited by this paper
• Calycosin Suppresses Breast Cancer Cell Growth via ERβ-Dependent Regulation of IGF-1R, p38 MAPK and PI3K/Akt Pathways

  2014cited by this paper
• Insulin-Like Growth Factor 1 Receptor (IGF-1R) as a Target of MiR-497 and Plasma IGF-1R Levels Associated with TNM Stage of Pancreatic Cancer

  2014cited by this paper
• Insulin-Like Growth Factor 1 Receptor Is a Prognostic Factor in Classical Hodgkin Lymphoma

  2014cited by this paper
• Metabolic syndrome and colorectal cancer: is hyperinsulinemia/insulin receptor-mediated angiogenesis a critical process?

  2014cited by this paper
• The type 1 insulin-like growth factor receptor signalling system and targeted tyrosine kinase inhibition in cancer

  2013cited by this paper
• MicroRNA-503 acts as a tumor suppressor in glioblastoma for multiple antitumor effects by targeting IGF-1R

  2013cited by this paper
• Targeting EGFR and IGF 1R: a promising combination therapy for metastatic cancer.

  2013cited by this paper
• MiRNA-181b suppresses IGF-1R and functions as a tumor suppressor gene in gliomas.

  2013cited by this paper
• Downregulation of miR-383 promotes glioma cell invasion by targeting insulin-like growth factor 1 receptor

  2013cited by this paper
• Targeting the insulin-like growth factor receptor pathway in lung cancer: problems and pitfalls

  2012cited by this paper
• Potential Therapeutic Strategies to Overcome Acquired Resistance to BRAF or MEK Inhibitors in BRAF Mutant Cancers

  2011cited by this paper
• Enhanced Efficacy of IGF1R Inhibition in Pediatric Glioblastoma by Combinatorial Targeting of PDGFRα/β

  2011cited by this paper
• ENHANCED EFFICACY OF IGF1R INHIBITION IN PAEDIATRIC GLIOBLASTOMA BY COMBINATORIAL TARGETING OF PDGFRALPHA/BETA

  2010cited by this paper
• Type 1 insulin-like growth factor receptor translocates to the nucleus of human tumor cells.

  2010cited by this paper
• Malignant gliomas in adults.

  2008cited by this paper
• Cell proliferation and migration in glioblastoma multiforme cell lines are influenced by insulin-like growth factor I in vitro.

  2008cited by this paper
• Genetic causes of brain tumors: neurofibromatosis, tuberous sclerosis, von Hippel-Lindau, and other syndromes.

  2007cited by this paper
• Discontinuous fragmentation of nuclear DNA during apoptosis revealed by discrete “sub‐G1” peaks on DNA content histograms

  2007cited by this paper
• Loss of PTEN selectively desensitizes upstream IGF1 and insulin signaling

  2007cited by this paper
• Diarylureas are small-molecule inhibitors of insulin-like growth factor I receptor signaling and breast cancer cell growth

  2006cited by this paper
• Insulin-Like Growth Factor (IGF) family and prostate cancer.

  2006cited by this paper
• IGF1R signalling and its inhibition.

  2006cited by this paper
• Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma.

  2005cited by this paper
• The IGF receptor as anticancer treatment target.

  2004cited by this paper
• Nutrition, insulin, IGF-1 metabolism and cancer risk: a summary of epidemiological evidence.

  2004cited by this paper
• The therapeutic potential of agents targeting the type I insulin-like growth factor receptor

  2004cited by this paper
• The GH-IGF-I axis and breast cancer.

  2003cited by this paper
• Antitumor effects elicited by antisense-mediated downregulation of the insulin-like growth factor I receptor (review).

  1998cited by this paper

• Picropodophyllotoxin alters EMT in neuroblastoma via inhibition of surface receptors IFG1R and ALK.

  2025cites this paper
• Overexpression of lncRNA IRAIN restrains the progression and Temozolomide resistance of glioma via repressing IGF-1R-PI3K-NF-κB signaling pathway.

  2022cites this paper
• Multi-Omics Immune Interaction Networks in Lung Cancer Tumorigenesis, Proliferation, and Survival

  2022cites this paper
• Metabolic Strategies for Inhibiting Cancer Development.

  2021cites this paper
• Prognostic and Therapeutic Roles of the Insulin Growth Factor System in Glioblastoma

  2021cites this paper
• The Interplay Between Non-coding RNAs and Insulin-Like Growth Factor Signaling in the Pathogenesis of Neoplasia

  2021cites this paper
• Diarylureas as Antitumor Agents

  2021cites this paper
• Targeting RTK-PI3K-mTOR Axis in Gliomas: An Update

  2021cites this paper
• Novel Receptor Tyrosine Kinase Pathway Inhibitors for Targeted Radionuclide Therapy of Glioblastoma

  2021cites this paper
• Diarylureas as Antitumor Agents Diarylureas as Antitumor Agents

  2021cites this paper
• The Neutrally Charged Diarylurea Compound PQ401 Kills Antibiotic-Resistant and Antibiotic-Tolerant Staphylococcus aureus

  2020cites this paper
• Receptor tyrosine kinase targeting in glioblastoma: performance, limitations and future approaches

  2020cites this paper
• IGF-1R inhibitor PQ401 inhibits osteosarcoma cell proliferation, migration and colony formation.

  2019cites this paper
• Viability and migratory effects of IGF-1R inhibitor, PQ401, on triple negative breast cancer cells

  2019cites this paper
• Myeloid p38 MAPK signaling in intestinal homeostasis, inflammation and tumorigenesis = Señalización por la MAPK p38 de células mieloides en la homeostasis, inflamación y tumorogénesis intestinal

  2017cites this paper
• HASF (C3orf58) is a novel ligand of the insulin-like growth factor 1 receptor.

  2017cites this paper
• Targeting cellular pathways in glioblastoma multiforme

  2017cites this paper